AMGEN Inc. (NASDAQ:AMGN) currently has a daily average trading volume of 2.41M but it saw 2342509 shares traded in last market. With a market cap of 179.99B USD, the company’s current market price of $335.53 came rising about 0.92 while comparing to the previous closing price of $332.47. In past 52 weeks, the stock remained buoying in the range of price level as high as $346.85 and as low as $228.21.
Taking a look at 20-day trading activity of AMGEN Inc. (AMGN) gives us an average price of $329.24, while its current price level is -3.26% below from 52-week high level whereas it is 47.03% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $315.92 while that of 200 days or SMA-200 reads an average of $291.59. A closer look into the stock’s movement over the week reveals that its volatility is standing at 1.77% during that period while stretching the period over a month that increases to 2.10%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 65.40 which implies that the stock is in neutral territory.
Barclays upgraded its recommendation for the stock as a “Equal Weight” from “Underweight” on May 03, 2024 while assigning a price target range of $230-$300.
Over the week, AMGN’s stock price is moving 0.37% up while it is 7.97% when we observe its performance for the past one month. Year-to-date it is 16.50% up and over the past year, the stock is showing an upside performance of 44.55%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of 5 beat the consensus estimate of 4.49 for the same. In next quarter, company is expected to be making quarterly sales of $8.45B as analysts are expecting the sales for current fiscal year at $33.06B and seeing the company making $34.04B in sales next year. Moreover, analysts are in estimates of $8.33B for current-quarter revenue.
Currently, AMGEN Inc.’s total number of outstanding shares is 535.40M with 0.25% of that held by the insiders while 80.94% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 5.78% and return on equity (ROE) at 72.57%. It has a price to earnings ratio (P/E ratio) of 47.98 while having a 16.19 of forward P/E ratio. Stock’s beta reads 0.58. Stock has a price to book (P/B) ratio of 35.84 while price to sale or P/S ratio amounts to 6.13. Its return on asset (ROA) is 4.14% on average.
